Anti-Human ITGA2B_ITGB3 (Abciximab Biosimilar)
Catalog #500002
| Cat # | Size | Price | Quantity | |
|---|---|---|---|---|
| 500002 | 1 mg | $250.00 | ||
| 500002 | 5 mg | $750.00 | ||
| 500002 | 20 mg | $2,000.00 |
Product Details
Abciximab biosimilar is a chimeric monoclonal antibody fragment (Fab) that specifically binds to the glycoprotein IIb/IIIa receptor on platelets, inhibiting fibrinogen binding and preventing platelet aggregation. It is used as an antiplatelet agent to reduce the risk of thrombotic complications in percutaneous coronary interventions (PCI).
Specifications
| Clone | Abciximab |
|---|---|
| Reactivities | Human |
| Isotype | Human IgG1 |
| Recommended Isotype Control | Human IgG1 isotype control |
| Format | Liquid |
| Formluation | PBS, pH 7.4 |
| Sterility | 0.2 µm filtered |
| Clonality | Recombinant |
| Conjugation | Unconjugated |
| Immunogen | Human Glycoprotein IIb/IIIa Receptor |
| Host | CHO cells |
| Purity | >95% (HPLC, SDS-PAGE) |
| Endotoxin | < 1.0 EU/mg (LAL assay) |
| Grade | In vivo ready (RUO) |
| Application | Neutralization; Flow Cytometry; ELISA; WB |
| Purification | Protein A |
| Storage Conditions | 2-8 °C, Avoid freeze / thaw cycle |
| Shelf Life | 6 months |
| Regulatory Status | RUO |